全文获取类型
收费全文 | 6816篇 |
免费 | 352篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 73篇 |
儿科学 | 680篇 |
妇产科学 | 106篇 |
基础医学 | 546篇 |
口腔科学 | 96篇 |
临床医学 | 481篇 |
内科学 | 1735篇 |
皮肤病学 | 113篇 |
神经病学 | 352篇 |
特种医学 | 208篇 |
外科学 | 1248篇 |
综合类 | 138篇 |
一般理论 | 2篇 |
预防医学 | 227篇 |
眼科学 | 175篇 |
药学 | 399篇 |
中国医学 | 22篇 |
肿瘤学 | 594篇 |
出版年
2023年 | 70篇 |
2022年 | 124篇 |
2021年 | 218篇 |
2020年 | 130篇 |
2019年 | 198篇 |
2018年 | 247篇 |
2017年 | 142篇 |
2016年 | 219篇 |
2015年 | 172篇 |
2014年 | 300篇 |
2013年 | 355篇 |
2012年 | 553篇 |
2011年 | 531篇 |
2010年 | 349篇 |
2009年 | 262篇 |
2008年 | 444篇 |
2007年 | 446篇 |
2006年 | 344篇 |
2005年 | 326篇 |
2004年 | 275篇 |
2003年 | 249篇 |
2002年 | 220篇 |
2001年 | 102篇 |
2000年 | 93篇 |
1999年 | 80篇 |
1998年 | 50篇 |
1997年 | 30篇 |
1996年 | 44篇 |
1995年 | 31篇 |
1994年 | 31篇 |
1993年 | 20篇 |
1992年 | 54篇 |
1991年 | 56篇 |
1990年 | 39篇 |
1989年 | 35篇 |
1988年 | 29篇 |
1987年 | 29篇 |
1986年 | 30篇 |
1985年 | 31篇 |
1984年 | 19篇 |
1983年 | 14篇 |
1981年 | 23篇 |
1980年 | 10篇 |
1979年 | 15篇 |
1978年 | 16篇 |
1977年 | 25篇 |
1976年 | 26篇 |
1975年 | 10篇 |
1974年 | 11篇 |
1968年 | 8篇 |
排序方式: 共有7195条查询结果,搜索用时 15 毫秒
101.
Rinkesh K. Bansal Narendra S. Choudhary Saurabh K. Patle Amit Agarwal Gagandeep Kaur Haimanti Sarin Rajesh Puri 《Indian journal of gastroenterology》2018,37(2):108-112
Background
Fine-needle aspiration (FNA) of adrenals is needed in patients with pyrexia of unknown origin (PUO) and adrenal enlargement in absence of other diagnostic clues. Adrenals are easily accessible by endoscopic ultrasound (EUS) due to proximity; however, there is no systemic study available on FNA of adrenals in patients with PUO. The aim of this study was to evaluate the diagnostic yield and safety of EUS-FNA of enlarged adrenal in patients with PUO.Methods
Data was analyzed from October 2010 to September 2016 at a single tertiary care center in northern India. EUS-FNA of enlarged adrenals was done in 52 patients for the etiological diagnosis of PUO in whom a definitive diagnosis could not be made with other means.Results
The mean age was 48±14 years; 36 were males and 16 were females. EUS-FNA was done from the left adrenal in 50 patients and from the right sample in 2 patients. A technical success was achieved in 100% cases. The 19-G needle was used in the majority (75%) to the presence of necrotic areas in adrenals; median numbers of passes were 2. The cytopathological diagnoses were tuberculosis (n?=?36), histoplasmosis (n?=?13), lymphoma (n?=?2), and metastasis from undiagnosed neuroendocrine tumor of lung (n?=?1). Thus, a diagnosis could be made in 52/52 (100%) patients. None of the patients had any procedure-related complications.Conclusions
EUS-FNA is a safe and effective method for evaluating etiology of PUO in patients with adrenal enlargement.102.
The pattern of sequential relapses in 10 rhesus monkeys following inoculation of sporozoites of Plasmodium cynomolgi B has been studied after administering curative dose of chloroquine (5 mg/kg base X 7 days) to eliminate blood parasitaemia after each relapse. Observation for periods ranging from 109 to 245 days showed that the interval between first six relapses was 19.3 +/- 6.77 days (1st relapse), 20.9 +/- 8.43 days (2nd relapse), 22.8 +/- 8.55 days (3rd relapse), 27.8 +/- 10.0 days (4th relapse), 31.67 +/- 11.50 days (5th relapse) and 32.5 +/- 16.26 days (6th relapse). The results of this study indicate a gradual extension of the relapse interval in successive relapses. 相似文献
103.
104.
Puri V Ranjit S Konda S Nicoloro SM Straubhaar J Chawla A Chouinard M Lin C Burkart A Corvera S Perugini RA Czech MP 《Proceedings of the National Academy of Sciences of the United States of America》2008,105(22):7833-7838
Storage of energy as triglyceride in large adipose-specific lipid droplets is a fundamental need in all mammals. Efficient sequestration of fat in adipocytes also prevents fatty acid overload in skeletal muscle and liver, which can impair insulin signaling. Here we report that the Cide domain-containing protein Cidea, previously thought to be a mitochondrial protein, colocalizes around lipid droplets with perilipin, a regulator of lipolysis. Cidea-GFP greatly enhances lipid droplet size when ectopically expressed in preadipocytes or COS cells. These results explain previous findings showing that depletion of Cidea with RNAi markedly elevates lipolysis in human adipocytes. Like perilipin, Cidea and the related lipid droplet protein Cidec/FSP27 are controlled by peroxisome proliferator-activated receptor gamma (PPARgamma). Treatment of lean or obese mice with the PPARgamma agonist rosiglitazone markedly up-regulates Cidea expression in white adipose tissue (WAT), increasing lipid deposition. Strikingly, in both omental and s.c. WAT from BMI-matched obese humans, expression of Cidea, Cidec/FSP27, and perilipin correlates positively with insulin sensitivity (HOMA-IR index). Thus, Cidea and other lipid droplet proteins define a novel, highly regulated pathway of triglyceride deposition in human WAT. The data support a model whereby failure of this pathway results in ectopic lipid accumulation, insulin resistance, and its associated comorbidities in humans. 相似文献
105.
R K Saran K Bhandari V S Narain R C Ahuja V K Puri R Thakur S Dwivedi M Hasan 《International journal of cardiology》1990,28(2):209-213
We report the results of a randomized controlled trial of intravenous streptokinase in a subset of patients with unstable angina. Seventy-six patients were admitted with prolonged (more than 20 minutes) angina at rest of less than 3 weeks onset. Fifty-two patients continued to have more than 3 episodes of prolonged angina in 48 hours on medical therapy with metoprolol, isosorbide dinitrate, nifedipine and intravenous nitroglycerin. Forty-eight patients consented to enter the study and were randomized into two groups. The first group, of 24 patients, received 1.5 million units of streptokinase infusion and the second group, also of 24 patients, received a placebo. Pain relief within 48 hours was achieved in 19/24 (79.1%) patients after streptokinase infusion as compared to 9/24 (37.5%) of the controls (P less than 0.05). Approximately 90% (17/19) of patients responding to streptokinase therapy were relieved of chest pain within the first six hours as against none in the controls. The incidence of acute myocardial infarction within six months was 12.5% (3/24) in those receiving streptokinase and 25% (6/24) in the controls. Mortality at six months stood at 8.33% (2/24) in the treated patients and 16.6% (4/24) in the controls. Intravenous streptokinase thus appears to be of benefit in patients with angina at rest of recent onset which does not respond to conventional medical therapy. 相似文献
106.
Ajay J Kirtane Jonathan J Vafai Sabina A Murphy Julian M Aroesty Marc S Sabatine Christopher P Cannon C Michael Gibson 《European heart journal》2006,27(17):2040-2045
AIMS: The presence of residual thrombus following fibrinolytic therapy for ST-segment elevation myocardial infarction (STEMI) may predispose to greater embolization and microvascular dysfunction. METHODS AND RESULTS: We hypothesized that even in the presence of a patent epicardial artery, residual thrombus would be associated with worsened TIMI myocardial perfusion grades (TMPG), independent of epicardial flow. Data were analysed from the angiograms of 2684 patients enrolled in the CLARITY-TIMI 28 trial, with angiographically patent arteries (TIMI 2/3 flow) at a median of 88 h following fibrinolytic therapy. Thrombus in a patent epicardial artery was observed more frequently among patients with shorter times from randomization to angiography, among patients with non-left anterior descending infarctions, and among patients treated with placebo (vs. clopidogrel). Thrombus was associated with more frequent TIMI 2 flow (35.1 vs. 22.1%, P < 0.001), higher corrected TIMI frame counts (CTFC) (42 vs. 33 frames, P < 0.001), and a lower incidence of normal TMPG 3 (48.7 vs. 63.9%, P < 0.001), irrespective of treatment with clopidogrel or placebo. In multivariable analyses, thrombus remained associated with higher CTFC (P < 0.001) and worse TMPG (OR 1.6 for TMPG 0/1/2, P < 0.001) after adjustment for baseline covariates as well as known correlates of TMPG. The association between thrombus and impaired TMPG remained even after further adjustment for CTFC or TIMI flow grade. CONCLUSION: Residual angiographic thrombus following fibrinolytic therapy in STEMI patients is associated with impaired myocardial perfusion, independent of epicardial flow. This finding emphasizes the roles of platelet aggregation and distal embolization in the pathogenesis of microvascular dysfunction in STEMI. 相似文献
107.
108.
Small intestine in hookworm disease 总被引:2,自引:0,他引:2
109.
Vardhmaan Jain MD Ankur Kalra MD Muhammad Siyab Panhwar MD Agam Bansal MD Amy Nowacki PhD Kirtipal Bhatia MD Tanush Gupta MD Nichole L. Ineman MSN Safi U. Khan MD Amar Krishnaswamy MD Grant W. Reed MD Rishi Puri MBBS PhD Samir R. Kapadia MD Lars G. Svensson MD PhD Anmar Kanaa'N MD Joseph A. Lahorra MD 《Journal of the American Geriatrics Society》2021,69(5):1363-1369
110.
Harry Gibbs Ben Freedman Mårten Rosenqvist Saverio Virdone Wael Al Mahmeed Giuseppe Ambrosio A. John Camm Barry Jacobson Carlos Jerjes-Sanchez Gloria Kayani Ali Oto Elizaveta Panchenko Hany Ragy Ajay K. Kakkar 《The American journal of medicine》2021,134(7):893-901.e11
BackgroundAsymptomatic atrial fibrillation is often detected incidentally. Prognosis and optimal therapy for asymptomatic compared with symptomatic atrial fibrillation is uncertain. This study compares clinical characteristics, treatment, and 2-year outcomes of asymptomatic and symptomatic atrial fibrillation presentations.MethodsGlobal Anticoagulant Registry in the Field-Atrial Fibrillation (GARFIELD-AF) is a global, prospective, observational study of newly diagnosed atrial fibrillation with ≥1 stroke risk factors (http://www.clinicaltrials.gov, unique identifier: NCT01090362). Patients were characterized by atrial fibrillation-related symptoms at presentation and the CHA2DS2-VASc score. Two-year follow-up recorded anticoagulation patterns (vitamin K antagonist, direct oral anticoagulants, parenteral therapy) and outcomes (stroke/systemic embolism, all-cause mortality, and bleeding).ResultsAt presentation, of 52,032 eligible patients, 25.4% were asymptomatic and 74.6% symptomatic. Asymptomatic patients were slightly older (72 vs 70 years), more often male (64.2% vs 52.9%), and more frequently initiated on anticoagulation ± antiplatelets (69.4% vs 66.0%). No difference in events (adjusted hazard ratios, 95% confidence interval) for nonhemorrhagic stroke/systemic embolism (1.19, 0.97-1.45), all-cause mortality (1.06, 0.94-1.20), or bleeding (1.02, 0.87-1.19) was observed. Anticoagulation was associated with comparable reduction in nonhemorrhagic stroke/systemic embolism (0.59, 0.43–0.82 vs 0.78, 0.65–0.93) and all-cause mortality (0.69, 0.59-0.81 vs 0.77, 0.71-0.85) in asymptomatic versus symptomatic, respectively.ConclusionsMajor outcomes do not differ between asymptomatic and symptomatic atrial fibrillation presentations and are comparably reduced by anticoagulation. Opportunistic screening-detected asymptomatic atrial fibrillation likely has the same prognosis as asymptomatic atrial fibrillation at presentation and likely responds similarly to anticoagulation thromboprophylaxis. 相似文献